ARQT Free Cash Flow
$39.15MTTM · USD
Period ending:
ARQT FY Free Cash FlowUSD
$0.00-$281.00M
2017-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
ARQT free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -6,311,000 | |
| -112,301,000 | |
| -247,485,000 | |
| -280,998,000 | |
| -175,622,000 | |
| -113,354,000 | |
| -43,131,000 | |
| -14,085,000 | |
| -3,775,000 |
Compare free cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) free cash flow
- Bridgebio Pharma Inc (BBIO) free cash flow
- Brightspring Health Services Inc (BTSG) free cash flow
- Madrigal Pharmaceuticals Inc (MDGL) free cash flow
- Ensign Group Inc (ENSG) free cash flow
- Glaukos Corp (GKOS) free cash flow
- Vaxcyte Inc (PCVX) free cash flow
- Krystal Biotech Inc (KRYS) free cash flow
All ARQT financial metrics · ARQT stock overview · How to interpret financial metrics
